| Dr Erin Foster, MD, PHD | |
|
3303 S Bond Ave, Portland, OR 97239-4501 | |
| (503) 418-3376 | |
| Not Available |
| Full Name | Dr Erin Foster |
|---|---|
| Gender | Female |
| Speciality | Dermatology |
| Experience | 8 Years |
| Location | 3303 S Bond Ave, Portland, Oregon |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1962858324 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | PG193069 (Oregon) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ohsu Hospital And Clinics | Portland, OR | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Oregon Health And Sciences University/university Medical Group | 4880760107 | 1485 |
News Archive
Young women are more likely to experience sleep disruption in the days leading up to their menstrual period, according to a new study that will be presented Saturday at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
New York University College of Nursing (NYUCN) received a five-year, $7.56 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to evaluate the efficacy and cost-effectiveness of a peer-driven intervention to seek out heterosexuals at high risk for HIV in their communities, test them for HIV, and link them to care in a timely fashion if they are found to be HIV infected.
New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
| Entity Name | University Professional Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376709535 PECOS PAC ID: 4880760107 Enrollment ID: O20080910000013 |
News Archive
Young women are more likely to experience sleep disruption in the days leading up to their menstrual period, according to a new study that will be presented Saturday at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
New York University College of Nursing (NYUCN) received a five-year, $7.56 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to evaluate the efficacy and cost-effectiveness of a peer-driven intervention to seek out heterosexuals at high risk for HIV in their communities, test them for HIV, and link them to care in a timely fashion if they are found to be HIV infected.
New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin Foster, MD, PHD 3303 S Bond Ave, Portland, OR 97239-4501 Ph: (503) 418-3376 | Dr Erin Foster, MD, PHD 3303 S Bond Ave, Portland, OR 97239-4501 Ph: (503) 418-3376 |
News Archive
Young women are more likely to experience sleep disruption in the days leading up to their menstrual period, according to a new study that will be presented Saturday at ENDO 2019, the annual meeting of the Endocrine Society, in New Orleans, La.
Researchers have found that a novel form of personalized therapy that genetically engineers a patient's own anti-tumor immune cells to fight tumors could treat metastatic melanoma and metastatic synovial cell sarcoma, representing a potentially new therapeutic approach against these and other cancers.
New York University College of Nursing (NYUCN) received a five-year, $7.56 million grant from the National Institute on Drug Abuse (NIDA) at the National Institutes of Health (NIH) to evaluate the efficacy and cost-effectiveness of a peer-driven intervention to seek out heterosexuals at high risk for HIV in their communities, test them for HIV, and link them to care in a timely fashion if they are found to be HIV infected.
New research suggests that increased consumption of foods containing colorful carotenoids, particularly beta-carotene and lutein, may prevent or delay the onset of amyotrophic lateral sclerosis (ALS).
› Verified 1 days ago
Dr. Alison Marie Small, M.D. Dermatology Medicare: Medicare Enrolled Practice Location: 3303 Sw Bond Ave, Portland, OR 97239 Phone: 503-418-3376 | |
Milie Fang, DO Dermatology Medicare: Not Enrolled in Medicare Practice Location: 3303 S Bond Ave Dept, Portland, OR 97239 Phone: 503-494-1375 | |
Bert G Tavelli, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2525 Nw Lovejoy St Ste 400, Portland, OR 97210 Phone: 503-223-1933 Fax: 503-223-1947 | |
Natasha Fewkes Carter, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4914 Sw 1st Ave, Portland, OR 97239 Phone: 310-701-8274 | |
Dr. Samuel Fritz Bremmer, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 3181 Sw Sam Jackson Park Rd, Portland, OR 97239 Phone: 503-494-8211 | |
Oluwadamilare Olalekan Ajayi, MD Dermatology Medicare: Medicare Enrolled Practice Location: 3303 S Bond Ave, Portland, OR 97239 Phone: 503-418-3376 Fax: 503-494-6968 | |
Diane Romayne Baker, MD Dermatology Medicare: Not Enrolled in Medicare Practice Location: 9495 Sw Locust St Ste A&e, Portland, OR 97223 Phone: 503-471-0500 Fax: 503-471-0504 |